tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ACRV Stock Latest News

Acrivon Therapeutics Reports Progress in Cancer Drug Development
Company AnnouncementsAcrivon Therapeutics Reports Progress in Cancer Drug Development
2h ago
ACRV
Acrivon Therapeutics Appoints New Chief Medical Officer
PremiumCompany Announcements
Acrivon Therapeutics Appoints New Chief Medical Officer
9h ago
8K
ACRV
Acrivon appoints Mansoor Raza Mirza as Chief Medical Officer
PremiumThe Fly
Acrivon appoints Mansoor Raza Mirza as Chief Medical Officer
10h ago
ACRV
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position
PremiumRatings
Buy Rating Reaffirmed for Acrivon Therapeutics Amid Promising Endometrial Cancer Data and Strong Financial Position
6d ago
ACRV
Acrivon Therapeutics price target lowered to $7 from $22 at JonesResearch
PremiumThe Fly
Acrivon Therapeutics price target lowered to $7 from $22 at JonesResearch
7d ago
ACRV
Acrivon Therapeutics price target lowered to $10 from $18 at Oppenheimer
PremiumThe FlyAcrivon Therapeutics price target lowered to $10 from $18 at Oppenheimer
11d ago
ACRV
Acrivon Therapeutics reports Q4 EPS (60c), consensus (70c)
Premium
The Fly
Acrivon Therapeutics reports Q4 EPS (60c), consensus (70c)
11d ago
ACRV
Acrivon Therapeutics Reports 2024 Financial Results and Progress
Premium
Company Announcements
Acrivon Therapeutics Reports 2024 Financial Results and Progress
11d ago
8K
ACRV
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating
PremiumRatings
Promising Phase 2 Results for ACR-368 in Endometrial Cancer Justify Buy Rating
13d ago
ACRV
Acrivon Therapeutics price target lowered to $19 from $22 at H.C. Wainwright
PremiumThe Fly
Acrivon Therapeutics price target lowered to $19 from $22 at H.C. Wainwright
13d ago
ACRV
Acrivon Therapeutics, Inc. (ACRV) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Acrivon Therapeutics, Inc. (ACRV) Q4 Earnings Cheat Sheet
15d ago
ACRV
Acrivon Therapeutics: Promising Oncology Advancements and Strategic Positioning Justify Buy Rating
PremiumRatings
Acrivon Therapeutics: Promising Oncology Advancements and Strategic Positioning Justify Buy Rating
15d ago
ACRV
Acrivon Therapeutics Appoints New Chief Financial Officer
PremiumCompany AnnouncementsAcrivon Therapeutics Appoints New Chief Financial Officer
24d ago
8K
ACRV
Acrivon Therapeutics announces FDA granted BDD for ACR-368
Premium
The Fly
Acrivon Therapeutics announces FDA granted BDD for ACR-368
2M ago
ACRV
Acrivon Therapeutics initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
Acrivon Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
ACRV
Acrivon Therapeutics Reports Promising Clinical Progress and Financial Results
PremiumCompany Announcements
Acrivon Therapeutics Reports Promising Clinical Progress and Financial Results
5M ago
ACRV
Acrivon Therapeutics reports Q3 EPS (59c), consensus (58c)
PremiumThe Fly
Acrivon Therapeutics reports Q3 EPS (59c), consensus (58c)
5M ago
ACRV
Acrivon Therapeutics sees cash runway into 2H26
PremiumThe Fly
Acrivon Therapeutics sees cash runway into 2H26
5M ago
ACRV
Acrivon Therapeutics to presents data on deployment of AP3 platform
PremiumThe Fly
Acrivon Therapeutics to presents data on deployment of AP3 platform
6M ago
ACRV
Acrivon Therapeutics Launches Phase 1 Cancer Trial, Advances Oncology Pipeline
PremiumCompany AnnouncementsAcrivon Therapeutics Launches Phase 1 Cancer Trial, Advances Oncology Pipeline
6M ago
8K
ACRV
Acrivon announces initial patient dosing in Phase 1 trial of ACR-2316
Premium
The Fly
Acrivon announces initial patient dosing in Phase 1 trial of ACR-2316
6M ago
ACRV
Acrivon Therapeutics price target raised to $28 from $25 at BMO Capital
Premium
The Fly
Acrivon Therapeutics price target raised to $28 from $25 at BMO Capital
7M ago
ACRV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >